<p>The invention concerns the use of recombinant clonotypic immunoglobulins (Ig) as a vaccine in the treatment of HCV-related and non HCV-related lymphoproliferations, in particular the use of recombinant proteins with immunogenic properties derived from protein segments VK3-20 and VK3-15 of Ig light chains derived from patients with lymphoproliferations.</p>
申请公布号
CA2694127(A1)
申请公布日期
2009.02.05
申请号
CA20082694127
申请日期
2008.07.24
申请人
ARETA INTERNATIONAL S.R.L.
发明人
DOLCETTI, RICCARDO;GUIDOBONI, MASSIMO;DE RE, VALLI;GASPAROTTO, DANIELA;CASTIGLIONI, SONIA;NOLLI, MARIA LUISA